Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF‐TIMI 48
Giulia Magnani, Robert P. Giugliano, Christian T. Ruff, et al.
European Journal of Heart Failure (2016) Vol. 18, Iss. 9, pp. 1153-1161
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Paul A. Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Circulation (2022) Vol. 145, Iss. 18
Open Access | Times Cited: 2991
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel, Peter Verhamme, Tatjana Potpara, et al.
European Heart Journal (2018) Vol. 39, Iss. 16, pp. 1330-1393
Open Access | Times Cited: 1903
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Paul A. Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 17, pp. e263-e421
Open Access | Times Cited: 1497
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Jan Steffel, Rónán Collins, Matthias Antz, et al.
EP Europace (2021) Vol. 23, Iss. 10, pp. 1612-1676
Open Access | Times Cited: 820
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Paul A. Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Circulation (2022) Vol. 145, Iss. 18
Open Access | Times Cited: 624
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
Paul A. Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 17, pp. 1757-1780
Open Access | Times Cited: 580
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono K, Yu‐ki Iwasaki, Masaharu Akao, et al.
Circulation Journal (2022) Vol. 86, Iss. 11, pp. 1790-1924
Open Access | Times Cited: 83
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: Executive Summary
Paul A. Heidenreich, Biykem Bozkurt, David Aguilar, et al.
Journal of Cardiac Failure (2022) Vol. 28, Iss. 5, pp. 810-830
Closed Access | Times Cited: 72
Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling
Jan Steffel, Robert P. Giugliano, Eugene Braunwald, et al.
Journal of the American College of Cardiology (2016) Vol. 68, Iss. 11, pp. 1169-1178
Open Access | Times Cited: 145
The myth of ‘stable’ coronary artery disease
Keith A.A. Fox, Marco Metra, João Morais, et al.
Nature Reviews Cardiology (2019) Vol. 17, Iss. 1, pp. 9-21
Closed Access | Times Cited: 126
Heart Failure as a Risk Factor for Stroke
Woohyeun Kim, Eung Ju Kim
Journal of Stroke (2018) Vol. 20, Iss. 1, pp. 33-45
Open Access | Times Cited: 112
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial
Tze‐Fan Chao, Shih‐Ann Chen, Christian T. Ruff, et al.
European Heart Journal (2018) Vol. 40, Iss. 19, pp. 1518-1527
Closed Access | Times Cited: 84
Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure
Gianluigi Savarese, Robert P. Giugliano, Giuseppe Rosano, et al.
JACC Heart Failure (2016) Vol. 4, Iss. 11, pp. 870-880
Open Access | Times Cited: 66
Left atrial structure and function and the risk of death or heart failure in atrial fibrillation
Riccardo M. Inciardi, Robert P. Giugliano, Brian Claggett, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 12, pp. 1571-1579
Open Access | Times Cited: 58
Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes
Riccardo M. Inciardi, Robert P. Giugliano, Jeong‐Gun Park, et al.
JACC. Clinical electrophysiology (2023) Vol. 9, Iss. 4, pp. 569-580
Open Access | Times Cited: 16
Atrial Fibrillation and Heart Failure
Jonathan P. Ariyaratnam, Dennis H. Lau, Prashanthan Sanders, et al.
Cardiac Electrophysiology Clinics (2021) Vol. 13, Iss. 1, pp. 47-62
Closed Access | Times Cited: 34
Apixaban in patients with nonvalvular atrial fibrillation, heart failure and low body weight: A report from a global federated research dataset
Luca Monzo, Guillaume Baudry, Gema Hernandez, et al.
European Journal of Clinical Investigation (2025)
Open Access
JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono K, Yu‐ki Iwasaki, Masaharu Akao, et al.
Journal of Arrhythmia (2022) Vol. 38, Iss. 6, pp. 833-973
Open Access | Times Cited: 19
Clinical outcomes and anticoagulation therapy in elderly non‐valvular atrial fibrillation and heart failure patients
Shota Ikeda, Ken‐ichi Hiasa, Hiroshi Inoue, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 2, pp. 902-913
Open Access | Times Cited: 4
Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications
Ju H. Kim, Palak Shah, Udaya S. Tantry, et al.
Current Heart Failure Reports (2016) Vol. 13, Iss. 6, pp. 319-328
Closed Access | Times Cited: 33
Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges
João Pedro Ferreira, Nicolas Girerd, Saleh Alshalash, et al.
European Heart Journal (2016) Vol. 37, Iss. 31, pp. 2455-2464
Open Access | Times Cited: 31
Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure
Alpesh Amin, Alessandra Bassalobre García, Xiaoyan Li, et al.
PLoS ONE (2019) Vol. 14, Iss. 3, pp. e0213614-e0213614
Open Access | Times Cited: 28
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Andreas Schäfer, Ulrike Flierl, Johann Bauersachs
Clinical Research in Cardiology (2021) Vol. 111, Iss. 1, pp. 1-13
Open Access | Times Cited: 20
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups
Bariş Gencer, Alon Eisen, David Berger, et al.
American Heart Journal (2022) Vol. 247, pp. 24-32
Open Access | Times Cited: 15
Anticoagulation in Heart Failure: a Review.
Emily P. Zeitler, Zubin J. Eapen
PubMed (2015) Vol. 8, Iss. 1, pp. 1250-1250
Closed Access | Times Cited: 25
Page 1 - Next Page

Scroll to top